Adyn is a precision medicine company that develops personalized birth control methods. It provides medically actionable scientific insights and empowers individuals to proactively optimize their health—from birth control to fertility and beyond. The company's first product, the Birth Control Optimization Test, is an at-home kit enabling users to collect both saliva and finger prick samples to measure hormone baseline levels and aims to assess genetic risk for blood clots and depression. Adyn's technology then synthesizes a medical biography with side effect profiles of estrogens and progestins used in hormonal contraception. Elizabeth Ruzzo headquartered the company in Seattle, Washington in 2019 and is backed by Lux Capital, M13, Civilization Ventures, Concrete Rose Capital, Y Combinator, Madrona Pioneer Fund, and Ascend VC.
Alternative investments have become a growing staple in investor portfolios as investors continue to seek better portfolio diversification and higher returns. However investing in and alongside the most promising venture funds is primarily limited to institutional investors and industry insiders. We are here to change that.
AllVoices is an employee feedback management platform that enables employees to report issues and share feedback directly with their company's leadership. With AllVoices, companies have access to real-time, proactive data that helps them identify issues before they become systemic problems, helping them improve culture holistically while providing a safe place for employees to feel heard. For more information, please email info@allvoices.co.